A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain

NCT00662558 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

802

Enrollment

INDUSTRY

Sponsor class

Conditions

Low Back Pain

Interventions

DRUG: celecoxib
DRUG: tramadol HCL

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.